local_hospital

Prywatna Praktyka Lekarska Ewa Ring

Address
lock Available on a paid plan

Prywatna Praktyka Lekarska Ewa Ring - Dermatological Research Center

Prywatna Praktyka Lekarska Ewa Ring is a private medical practice specializing in clinical research focused on chronic inflammatory dermatological conditions. The center demonstrates particular expertise in evaluating long-term therapeutic interventions for complex skin disorders that significantly impact patients' quality of life.

  • Hidradenitis suppurativa treatment and management
  • Biologic therapy efficacy and safety assessment
  • Long-term dosing regimen optimization studies

The center conducts sophisticated extension studies examining secukinumab therapy in patients with moderate to severe hidradenitis suppurativa. Their research focuses on comparing continuous versus interrupted treatment protocols and evaluating different dosing frequencies to optimize therapeutic outcomes while maintaining safety profiles. This work contributes valuable insights into long-term disease management strategies and helps establish evidence-based treatment protocols for patients with chronic inflammatory skin conditions.

Site Overview

assignment
5
connected trials
corporate_fare
4
sponsors
science
4
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
5
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
4
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
5
Outperforms 67% of sites
public
Therapeutic diversity
1areas
Outperforms 1% of sites
groups
Sponsor diversity
4sponsors
Outperforms 66% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Prywatna Praktyka Lekarska Ewa Ring

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Multicenter, Double-Blind, Randomized Withdrawal Study of Subcutaneous Secukinumab for Long-Term Efficacy and Safety in Moderate to Severe Hidradenitis SuppurativaNovartis Pharma AGPhase IIINot RecruitingMar 2020Jun 2026

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Apg7772Unknown2024-09-032025-10-06

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.